New vaccines: challenges of discovery

Targeting neoantigens for cancer immunotherapy: Table 1.

(2016) Yong-Chen Lu et al.   INTERNATIONAL IMMUNOLOGY

Immunogenicity of a Meningococcal B Vaccine during a University Outbreak

(2016) Nicole E. Basta et al.   NEW ENGLAND JOURNAL OF MEDICINE

From the RNA world to the clinic

(2016) B. A. Sullenger et al.   SCIENCE

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

(2015) Cornelia L Trimble et al.   LANCET

Establishing a Global Vaccine-Development Fund

(2015) Stanley A. Plotkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

Protectome Analysis: A New Selective Bioinformatics Tool for Bacterial Vaccine Candidate Discovery

(2014) Emrah Altindis et al.   MOLECULAR & CELLULAR PROTEOMICS

Vaccines, new opportunities for a new society

(2014) R. Rappuoli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Global Road Map Is Needed For Vaccine Research, Development, And Deployment

(2011) Adel Mahmoud   HEALTH AFFAIRS